[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
More about BioMed Central
- To: liblicense-l@lists.yale.edu
- Subject: More about BioMed Central
- From: Ann Okerson <ann.okerson@yale.edu>
- Date: Fri, 11 Jan 2002 05:42:38 -0500 (EST)
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
With permission from David Worlock of EPS. _____ EPS Update Note: 9 January 2002 BIOMED CENTRAL: STILL CHANGING THE RULES On the web at http://www.epsltd.com/UpdateNotes/Today.htm * The announcement of an institutional scheme for funding free and open access to peer-reviewed research could be a critical success factor for BioMed Central in 2002. ************************************ BioMed Central is changing its pricing policy from 1 January 2002. The company who challenged the subscription-based business model of traditional STM journal publishers by charging academics USD500 per accepted article and by providing free access to all peer-reviewed material published, has now introduced an institutional scheme. This allows for annual membership at rates ranging from USD1,500 (for 20-500 full time researchers and postgraduates) to USD7,500 (for more than 5,000 staff). This has several neat effects. On the one hand, it removes a number of problems associated with the individual writer's status (research team member, institutional staff member etc) and recognises that increasingly, institutions want a greater say in the downstream management of their intellectual property (if it is, wholly or in part, their own). It also provides additional value to institutions, which they can offer to researchers who they seek to recruit, and provides an inducement to publish that aligns with the institution's needs as well as the individual's career requirements. And, of course, it preserves the free and open access policy which is clearly close to contributor/user perceptions of good practice. If there are enough institutions to make it work (and work fast enough - a not inconsiderable issue in itself), then this is another bold move from a publisher seemingly determined to recreate a scientific literature dissemination model that is derived directly from what users want. Finding the right budget holder in some institutions will be an issue. In others, especially where researchers individually would have been forced to invoke BioMed Central's waiver policy, there is a prospect of getting something where nothing was previously available. And if institutional support quickens the pace of BioMed Central's development, it will also enable it to expand its publishing activities more rapidly. It already has 60 e-journals with a further 20 planned this year. Institutions subscribing at the levels given above will also get 15% of BioMed Central's paid-for products (www.facultyof1000.com and www.images.MD). And finally, with a nod towards institutional vanity (a not inconsiderable force) and the deep desire to be in greater control of its generated output alluded to above, BioMed Central will create a customised web page on its site for abstracts of all articles written by a subscribing institution's academics, whether published by BioMed Central or not. These abstracts will be included in all relevant searches of the BioMed Central site, with links back to the full text on the institution's own library or proxy server. It would, of course, be deeply ironic, but not implausible, if publishing in STM returned to the subscription model via this route, and in the process created a very valuable (and highly acquirable) publishing asset at BioMed Central. But then, it would not be the first time in this market that last year's ironic twist turned into next year's normal trading practice. by David Worlock (drw@epsltd.com) � Electronic Publishing Services 2002 Comments? Contact the author on drw@epsltd.com What would you like us to write about? Contact lara@epsltd.com Want to reproduce EPS material? Contact jo@epsltd.com RELATED LINKS BioMed Central: http://www.biomedcentral.com FROM THE EPS ARCHIVE BioMed Central: if publishing adds real value, then authors should pay for it, EPS Update Note 26 July 2001 http://www.epsltd.com/database/updates/july01/july19.asp BioMed Central: a thousand reasons to pay for services, not content, EPS Update Note 15 October 2001 http://www.epsltd.com/database/updates/oct01/oct11.asp Serial Killers, imi May 2001 http://www.epsltd.com/database/imi/may01/serialkillers.asp ********************************************** STOP PRESS .....Next EPS/Keynote Conference ......STOP PRESS ********************************************** NEW NETWORK PUBLISHING Controlling the migration of content to private networks ********************************************** RSA London, one day conference, Wednesday 6th March 2002 Put the conference in your diary, get full details from our web site, http://www.epsltd.com/keynoteMarch2002.Main.htm Be sure to register before the end of January to get your 10% Earlybird discount! 'Networks are user-centric, publishers are not' *Creating new opportunities on intranets and extranets *Commercialising in-house knowledge *Becoming a network publisher *Using end-user content to add value *Projecting the future of networked publishing ******************************* Electronic Publishing Services Ltd 26 Rosebery Avenue London EC1R 4SX, UK Tel: +44 (0)20 7837 3345 Fax: +44 (0)20 7837 8901 Web: www.epsltd.com e-mail: epsinfo@epsltd.com
- Prev by Date: Limited Liability clauses
- Next by Date: RE: BMJ Journals publishing-what are they doing!
- Prev by thread: Re: Recent Pricing/Licensing Terms for Society Publications
- Next by thread: Limited Liability clauses
- Index(es):